Related Experiment Video
Updated: Oct 18, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
A case of COVID-19 vaccination-associated forme fruste purpura fulminans
J Griss1, S Eichinger2, S Winkler3
1Department of Dermatology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria.
Abstract:
We report the case of a female, 77 year old patient with multi-localized skin infarctions following vaccination with mRNA-1273 (Moderna). This phenomenon is to our knowledge otherwise only seen in infection-associated purpura fulminans - which was thoroughly ruled out in our patient. This report demonstrates that we need to be vigilant of a wider array of vascular phenomena related to Covid vaccinations.
Insights
A 77-year-old patient developed skin infarctions after receiving the Moderna COVID-19 vaccine (mRNA-1273). This rare vascular event, distinct from purpura fulminans, highlights the need for vigilance regarding vaccine-related side effects.
Area of Science:
- Dermatology
- Immunology
- Vascular Medicine
Background:
- The mRNA-1273 vaccine (Moderna) is a widely used COVID-19 vaccine.
- Skin infarctions are typically associated with severe conditions like purpura fulminans.
Observation:
- A 77-year-old female patient presented with multi-localized skin infarctions.
- The onset of skin infarctions occurred post-vaccination with mRNA-1273.
Findings:
- Infection-associated purpura fulminans was ruled out in this patient.
- The observed skin infarctions represent a rare vascular phenomenon potentially linked to mRNA-1273 vaccination.
Implications:
- This case suggests a broader spectrum of potential vascular side effects associated with COVID-19 mRNA vaccinations.
- Healthcare providers should maintain vigilance for unusual vascular events following vaccination.
- Further research is warranted to understand the mechanisms and incidence of such reactions.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pericarditis I: Introduction

